10 March 2022

Investor Webinar 10 March 2022

LCT invites investors to attend a webinar hosted by Executive Chairman, Professor Bernie Tuch, featuring a presentation from LCT Executive Chairman, Professor Bernie Tuch on the company’s activities including the third clinical trial of NTCELL in Parkinson’s disease, together with its strategy for 2022. 

DATE: Thursday 10 March 2022
TIME: from 11am AEDT (1pm NZ time) 
REGISTER: https://register.gotowebinar.c... 
ATTEND: https://attendee.gotowebinar.c... 
             Australia +61 2 9091 7604; New Zealand +64 4 974 7212
             Access code for attendees: 624-953-609
QUESTIONS: Attendees may submit questions to

 the company prior to the event or during the webinar via the control panel

A recording will also be made available following the webinar via LCT’s website and social media.